Pro-Dex Inc New (PDEX) is a publicly traded Healthcare sector company. As of May 21, 2026, PDEX trades at $63.59 with a market cap of $188.88M and a P/E ratio of 18.23. PDEX moved +2.55% today. Year to date, PDEX is +63.92%; over the trailing twelve months it is +42.41%. Its 52-week range spans $23.47 to $70.26. Rallies surfaces PDEX's financials, insider trades, hedge fund holdings, congressional trades, analyst ratings, and AI-generated research below.
Who is trading PDEX stock inside the company?
Recent PDEX insider activity includes CABILLOT RAYMOND E sold 7.26K, CABILLOT RAYMOND E sold 836, CABILLOT RAYMOND E sold 842, CABILLOT RAYMOND E sold 3.10K, and CABILLOT RAYMOND E sold 12.47K. Rallies tracks insider transaction dates, shares, prices, and estimated values.
PDEX Key Metrics
Key financial metrics for PDEX
Metric
Value
Price
$63.59
Market Cap
$188.88M
P/E Ratio
18.23
EPS
$3.48
Dividend Yield
0.00%
52-Week High
$70.26
52-Week Low
$23.47
Volume
2
Avg Volume
0
Revenue (TTM)
$72.10M
Net Income
$2.52M
Gross Margin
28.29%
Recent PDEX Insider Trades
CABILLOT RAYMOND E sold 7.26K (~$363.22K) on Apr 1, 2025.
CABILLOT RAYMOND E sold 836 (~$41.80K) on Mar 31, 2025.
CABILLOT RAYMOND E sold 842 (~$42.10K) on Mar 28, 2025.
CABILLOT RAYMOND E sold 3.10K (~$155.20K) on Mar 26, 2025.
CABILLOT RAYMOND E sold 12.47K (~$626.87K) on Mar 25, 2025.
PDEX analyst coverage data. Average price target: $0.00.
Common questions about PDEX
Who is trading PDEX stock inside the company?
Recent PDEX insider activity includes CABILLOT RAYMOND E sold 7.26K, CABILLOT RAYMOND E sold 836, CABILLOT RAYMOND E sold 842, CABILLOT RAYMOND E sold 3.10K, and CABILLOT RAYMOND E sold 12.47K. Rallies tracks insider transaction dates, shares, prices, and estimated values.
Does Rallies show Form 4 insider transactions for PDEX?
Yes. Rallies tracks PDEX insider trading and Form 4 activity, including executive purchases, executive sales, transaction dates, shares, and prices when available.
Is PDEX research on Rallies investment advice?
No. Rallies provides research, data, and educational context for PDEX. It does not provide personalized investment advice.
